Early stratification of acute arthritis
Official title: Early STratification of Acute ARThritis (START)- A Prospective Observational Study
Run by Diakonhjemmet Hospital · NCT07106931 · Data updated 2026-11-12
The project will collect clinical information and biomarker samples to try to find signs that help classify and guide treatment for adults who developed inflammatory arthritis symptoms within the past 12 weeks.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Diakonhjemmet Hospital Academic / other |
| Locations | 1 site (Oslo) |
| Status | Recruiting |
| Started | November 5, 2024 |
| Main results expected | December 31, 2044 |
| Study ends | December 31, 2044 |
| Registry record updated | August 6, 2025 |
| Trial ID | NCT07106931 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (over 18) with clinically active synovitis in at least one joint of less than 12 weeks' duration who can provide informed consent are eligible candidates.
✕Probably not a fit
People whose swelling is clearly due to trauma, those with symptoms longer than 12 weeks, children under 18, or individuals unable to follow the protocol are unlikely to receive direct benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
START is a prospective observational cohort enrolling adults with active synovitis of less than 12 weeks to build a platform for biomarker discovery and validation. Participants receive standardized clinical evaluation, possible ultrasound confirmation, and collection of biological samples without any experimental treatments. The effort aims to identify markers that distinguish types of inflammatory joint disease, detect infection, and predict the most appropriate initial management. Results from a large, well-characterized patient sample will be used to develop tools for earlier diagnosis and more personalized therapy.
Why it matters
Potential benefit: If successful, the platform could enable earlier, more accurate diagnosis and help clinicians choose the right initial treatment tailored to each patient's type of arthritis.
How similar studies have gone: Previous early arthritis cohorts and biomarker studies have produced promising leads but have not yet delivered widely adopted clinical stratification tools, so this work builds on encouraging but incomplete evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Arthritis\* in one or more joints of less than 12 weeks' duration\*\* * Adult patients (\> 18 years) capable of understanding and signing an informed consent form * Defined as currently active clinical synovitis (ie, swelling) in at least one joint as determined by an expert assessor which might be confirmed by ultrasonography \*\* Prior patient reported swollen joint not confirmed as arthritis by a rheumatologist is not an exclusion Exclusion Criteria: * Swollen joint related to trauma * Subject not capable of adhering to the study protocol
Where it's running
-
Diakonhjemmet Hospital
Oslo, Norway Recruiting
Study contacts
- Study coordinator: Silje W Syversen, MD PhD
- Email: s.w.syversen@gmail.com
- Phone: +4792040315
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
Ultrasound Before Corticosteroid Injection for Arthritis
This trial tests whether applying ultrasound before a corticosteroid joint injection helps improve arthritis symptoms in adults with limb arthritis who need an injection.
-
Ultralow-dose PET scan to detect bone activity with 18F‑NaF
This trial tests whether a new high-sensitivity PET scan using a tiny amount of 18F‑sodium fluoride can produce clear bone images in adults with or without bone disease while cutting radiation exposure by 10–100 times.
-
Biophoton therapy for chronic severe arthritis pain relief
This study is testing if biophoton therapy can help people with chronic severe arthritis pain feel better over 12 weeks.
-
Examining the effects of different exercise levels on arthritis symptoms
This study tests how different amounts of exercise can help people with arthritis feel better over six months.
-
Understanding pain in inflammatory joint diseases
This project will follow people with inflammatory joint diseases who are starting or switching biological or targeted synthetic DMARDs to try to identify different pain types and see if central sensitization and cognitive function relate to persistent pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.